XYPHOS BIOSCIENCES
Xyphos Biosciences develops a CAR-T cell therapy platform called ACCEL (Advanced Cellular Control through Engineered Ligands), for treating relapsed hematological malignancies and solid tumors. The platform enables precise control of activity and targeting of universal CAR-T cell, termed convertibleCAR-T, using any tumor-specific full antibody and can add critical functionality to convertibleCAR-T cells.
XYPHOS BIOSCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.xyphosinc.com
Total Employee:
1+
Status:
Active
Contact:
(650) 243-2951
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Global Site Tag
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Celmed Biosciences
Celmed BioSciences develops cell therapy-based treatments for hematological, immunological, and neurological disorders.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nationโs leading comprehensive, integrated health systems.
Vasade Biosciences
Vasade Biosciences develops novel inhibitors of AC5 for cardioprotection against myocardial infarction and congestive heart failure.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.xyphosinc.com
- Host name: 107.0.153.160.host.secureserver.net
- IP address: 160.153.0.107
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Xyphos Biosciences"
Management Team - Xyphos Biosciences, Inc.
Xyphos is led by a team with decades of experience in the research, development and commercialization of biotech-based human therapeutics within the biotechnology and โฆSee details»
Xyphos Biosciences, Inc.
At Xyphos, weโre working to deliver flexible and adaptable cancer therapies with the potential to revolutionize cancer care.See details»
Our Team - Xyphos Biosciences, Inc. - xyphosinc.com
Xyphos is committed to developing a flexible and controllable CAR-T cell therapy to provide patients with a potential cancer cure. Our ACCEL technology enables the precise control of โฆSee details»
Xyphos Company Profile | Management and Employees List
Www.xyphosinc.com . Contact Information. Headquarters. 100 Kimball Way, South San Francisco, California, 94080, United States (650) 243-2951. Xyphos Profile and History . Xyphos is โฆSee details»
Xyphos Biosciences - Crunchbase Company Profile
Xyphos Biosciences develops a CAR-T cell therapy platform for treating relapsed hematological malignancies and solid tumors.See details»
Org Chart Xyphos - The Official Board
For each of our 1,268,816 listed executives, discover their exact roles and their biographies.See details»
XYPHOS BIOSCIENCES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XYPHOS BIOSCIENCES, INC. of South San Francisco, CA. Get the latest business insights from Dun & โฆSee details»
Xyphos Biosciences: Contact Details and Business Profile
Xyphos, a privately held biotechnology company, is focused on the creation and development of immuno-oncology therapeutics designed to harness the power of a patientโs immune system โฆSee details»
Xyphos Company Profile - Office Locations, Competitors ... - Craft
Xyphos is a company developing a controllable CAR-T cell therapy to treat patients with cancer. Its ACCEL technology enables the control of CAR-T cells based on a tumor-specific antibody โฆSee details»
Xyphos - Company Profile - Tracxn
Feb 23, 2025 Website: xyphosinc.com; Phone Number: +1 ***** Key Metrics. Ranked. 518 th among 2508 active competitors. Employee Count. 9 as on Dec 31, 2022 . Similar Companies. โฆSee details»
Xyphos Biosciences, Inc. (Xyphos Biosciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Emerging leadership in allogeneic CAR-T for hematologic malignancies demonstrated by recent P-BCMA-ALLO1 Phase 1 data and new preclinical findings for P-CD19CD20-ALLO1 and P โฆSee details»
Xyphos Biosciences Company Overview, Contact Details
Keloniatx partnered with Xyphosinc on Feb 1st '24. Concurrently, in a strategic alliance poised to transform cancer therapy, Kelonia Therapeutics has joined forces with Xyphos Biosciences, an โฆSee details»
Xyphos - Overview, News & Similar companies | ZoomInfo.com
View Xyphos (www.xyphosinc.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Contact - Xyphos Biosciences, Inc.
For general inquiries, please fill out the form. For media inquiries, please click here. For more information about partnerships with Astellas, please contact us here. Xyphos, an Astellas โฆSee details»
Xyphos Biosciences - Products, Competitors, Financials, Employees ...
Xyphos Biosciences is a privately held development-stage biotechnology company that focuses on the creation and development of immuno-oncology therapeutics designed to harness the โฆSee details»
Xyphos Biosciences 2025 Company Profile: Valuation, Investors ...
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; AU-2021449810-A9: Antibody-nkg2d ligand domain fusion protein: Pending: 08-Jun-2021See details»
Careers - Xyphos Biosciences, Inc.
See our open positions And find out why youโll love Working at Astellas. Read about our dedication to nurturing a diverse, equitable and inclusive culture; find out more about our โฆSee details»
Astellas Strengthens Immuno-oncology Pipeline with Acquisition โฆ
Jan 3, 2020 "At Xyphos, we are driven to advance our innovative cell therapy technology platform as an exciting new approach to potentially manage and cure cancer," said James โฆSee details»
Innovation - Xyphos Biosciences, Inc.
Targeting transformational impact through flexible and adaptable therapy Our aspiration is to cure solid tumors with a precision, off-the-shelf โStandard Pharmaceutical like Cell Therapyโ โฆSee details»
Pipeline - Xyphos Biosciences, Inc.
We contribute to establishing a robust and competitive Cancer Cell Therapy pipeline at Astellas.See details»